Medically reviewed by ChinaCureLink Team
Table of Content
Introduction
If you are an Australian or New Zealand patient considering treatment overseas, cost can become one of the hardest parts of the decision. You may have already received a treatment plan, discovered that a particular medicine is not funded for your indication, or been told that a private pathway could involve a substantial personal expense.
Then you start searching for cancer treatment cost in China and the numbers can look dramatically different. But comparing one Chinese treatment price with one Australian or New Zealand price is rarely an apples-to-apples exercise. A drug price is not the same as a complete treatment journey, and an advertised private-care figure may exclude specialist fees, scans, medicines or hospital costs.
This guide explains the main cost differences between cancer treatment in China and private care in Australia and New Zealand, including CAR-T therapy, chemotherapy, immunotherapy, radiotherapy and surgery. It also explains what should be included in a quote, how deposits work, and what to ask before committing your family's money.
Key Takeaways |
|
What Does Cancer Treatment Cost in China?
China does not have one standard price for cancer treatment. A patient receiving surgery is in a completely different financial situation from someone receiving several cycles of immunotherapy or a personalised cellular therapy.
The most useful way to think about the cost is by treatment pathway.
Treatment pathway | China cost position | What to understand |
Surgery | Case-specific | Depends on cancer type, complexity, hospitalisation and reconstruction |
Chemotherapy | Case-specific | Depends heavily on medicines, cycles and monitoring |
Immunotherapy | Case-specific | Drug and treatment duration can substantially change the total |
Targeted therapy | Case-specific | Biomarker and medicine selection determine the pathway |
Precision medicine | Case-specific | Testing may be a separate cost from treatment |
CAR-T | USD $80,000–$150,000 total care | ChinaCureLink's current planning figure; final quote depends on case and protocol |
For CAR-T, ChinaCureLink currently uses USD $80,000–$150,000 as its standing total-care planning range. A ChinaCureLink page published in 2026 uses the same range for total CAR-T care.
Using the 24 September 2026 Xe mid-market rate of approximately USD 1 = AUD 1.422, that range is approximately:
AUD $142,200–$213,300.
Using the 24 September 2026 Xe mid-market rate of approximately USD 1 = NZD 1.760, it is approximately:
NZD $176,000–$264,000.
These are currency conversions, not Australian or New Zealand prices. Exchange rates change, and the rate your bank or payment provider gives you may be different from the mid-market rate.
The uncomfortable part is that a lower headline treatment price does not automatically mean a lower total cost. Flights, accommodation, additional diagnostic testing, medical interpretation, complications and a longer-than-expected stay can all add to the final amount.
How Does the Cost of Cancer Treatment in China Compare with Private Care in Australia?
Australia is difficult to compare with China using a single treatment-cost figure because the Australian system has several layers of payment.
A private cancer patient may have costs paid or partly subsidised through Medicare, the Pharmaceutical Benefits Scheme (PBS) and private health insurance. The patient's remaining cost can include specialist gaps, hospital excesses, co-payments, medicines and other services.
The Australian Government's Medical Costs Finder provides typical costs for individual medical services rather than one complete cancer-treatment price. It specifically warns that its figures are a guide and should not be treated as a quote.
For example, the Medical Costs Finder's national data for chemotherapy or immunotherapy in a private setting shows that specialist-fee out-of-pocket costs can be relatively modest for some patients because Medicare covers the relevant specialist service. That does not mean the complete cancer treatment is inexpensive:
medicines, hospital services, scans and other components can sit outside that particular figure.
Private cancer centres also explain that final costs vary according to the treatment plan, medicines and insurance arrangements. Icon Cancer Centre, for example, states that private chemotherapy costs depend on the treatment and medications and that uninsured patients can request a self-funded estimate.
This is why the right Australian comparison is not:
China price vs one Australian price.
It is:
China's complete quoted treatment pathway vs Australia's expected total personal cost for the same clinical pathway.
That distinction matters particularly for advanced treatments where the medicine itself may represent a large proportion of the total cost.
What Does Private Cancer Treatment Cost in New Zealand?
New Zealand has a similar problem with simple comparisons, although private treatment can be easier to price in some circumstances.
Most eligible New Zealand residents receive publicly funded cancer care, with Pharmac determining which medicines are publicly funded. Private care may involve specialist fees, treatment fees, medicines, imaging and hospital costs depending on the treatment.
Published New Zealand private-care estimates illustrate how wide the range can be. One 2026 cost guide based on insurer and other published sources gives indicative private costs of approximately:
Treatment or cancer pathway | Indicative private NZ cost |
Chemotherapy | NZD $15,000–$400,000 |
Pharmac-funded drugs | NZD $1,000–$7,000/month |
Non-Pharmac-funded drugs | NZD $8,000–$60,000/month |
Metastatic melanoma | NZD $100,000–$380,000 |
Lung cancer treatment | NZD $50,000–$300,000 |
Mastectomy | NZD $25,000–$50,000 |
Mastectomy + reconstruction | NZD $50,000–$100,000 |
Bowel resection | NZD $50,000–$80,000 |
Radiation therapy | NZD $20,000–$70,000 |
These figures are indicative private-care estimates, not hospital quotations, and the source itself notes that costs vary with cancer type, stage, hospital, specialist fees, treatment duration and whether medicines are Pharmac-funded.
That distinction is especially important for New Zealand patients. A medicine being approved for use does not necessarily mean Pharmac funds it for your particular cancer or line of treatment.
Private providers such as Canopy Cancer Care and Bowen Icon Cancer Centre also state that treatment costs depend on the individual treatment plan and that patients should receive a written estimate before treatment.
China vs Australia vs New Zealand: What Can You Actually Compare?
The most useful comparison is to separate published indicative costs from patient-specific quotations.
Cost question | China | Australia private | New Zealand private |
Complete cancer-treatment price | Usually case-specific | Case-specific | Case-specific |
CAR-T planning figure | USD $80k–$150k | Requires treatment-specific quote | Requires treatment-specific quote |
Chemotherapy | Case-specific | Medicare/PBS/private insurance can change patient cost | Published private estimates vary widely |
Immunotherapy | Case-specific | Medicine funding and insurance matter | Pharmac funding and insurance matter |
Radiotherapy | Case-specific | Medicare rebates and treatment plan matter | Published private estimates available |
Surgery | Case-specific | Hospital, surgeon, anaesthetist and insurance matter | Hospital and specialist fees matter |
International travel | Required | Usually not required | Usually not required |
Accommodation | May be required for treatment abroad | Usually local | Usually local |
Medical interpreting | May be required | Usually not required | Usually not required |
Currency risk | Yes | No | No |
Overseas follow-up coordination | Needs planning | Local system | Local system |
This table highlights something that is easy to miss in online comparisons: China introduces additional costs that Australian and New Zealand patients do not normally face at home.
At the same time, an Australian or New Zealand patient considering private care may face substantial costs for a medicine, procedure or treatment pathway that is not fully covered by insurance or public funding.
So the right comparison is always patient-specific.
For example, if your Chinese hospital quotes USD $120,000 for a defined CAR-T pathway, you should compare that against the total amount you would personally need to pay for the equivalent pathway in Australia or New Zealand, not against the Australian hospital's gross charge before Medicare and insurance.
What Should a Chinese Cancer-Treatment Quote Include?
This is where many families can protect themselves from unexpected costs.
A serious international-patient quotation should distinguish between the treatment itself and the surrounding costs.
Before making a deposit, ask whether the quote covers:
Initial medical assessment
Pathology review
Molecular or biomarker testing
Imaging
Medication
Treatment or infusion fees
Hospitalisation
Doctor and specialist fees
Nursing and monitoring
Management of expected treatment complications
Translation and interpretation
Follow-up consultation
Discharge documentation
You should also ask what is not included.
For CAR-T, this question becomes particularly important because the treatment pathway can involve multiple stages rather than one simple infusion. Your quote should make clear which parts of the pathway are included and what happens if your hospital stay becomes longer than expected.
ChinaCureLink's current published CAR-T cost information describes the USD $80,000–$150,000 figure as total care rather than simply the price of a drug.
Still, you should obtain a case-specific written quotation before relying on that range.
A range is useful for planning. It is not a promise of your final bill.
Do Chinese Hospitals Require a Deposit?
International hospitals may require payment or a deposit before treatment begins, but the amount and timing can vary by hospital and treatment.
Do not assume that a percentage mentioned on a medical-tourism website applies to every Chinese hospital.
Before transferring money, request written information covering:
The amount required before admission
The payment deadline
The account receiving the funds
The currency accepted
What the deposit covers
Whether unused funds are refundable
How additional hospital costs are handled
What happens if the patient is found medically ineligible after assessment
A legitimate payment process should be documented.
Your family should also understand whether you are paying the hospital directly or paying an intermediary for a separate service. Those are different transactions and should be explained separately.
Do not transfer a large amount based only on a WhatsApp message or verbal promise.
Ask for an official invoice, payment instructions and written treatment documentation.
What Extra Costs Should Australian and New Zealand Families Budget for?
Treatment is only one part of overseas cancer care.
If you travel to China, your budget may also need to cover flights, accommodation, meals, local transport, travel insurance where available, visa-related expenses, a companion's travel and accommodation, and unexpected extensions to your stay.
There may also be costs associated with additional medical testing requested after arrival.
Currency movement is another consideration. A treatment quoted in USD may cost a different amount in AUD or NZD by the time you actually transfer the money.
For this article, the 24 September 2026 Xe mid-market rates were approximately:
USD 1 = AUD 1.422
USD 1 = NZD 1.760
NZD 1 = AUD 0.807
These rates are dated 24 September 2026 and are for illustration. They are not guaranteed transfer rates.
For a large medical payment, ask the hospital or care coordinator which currency the invoice will be issued in and whether the final amount must be paid in full before treatment.
Is Cancer Treatment in China Actually Cheaper?
Sometimes the total quoted treatment cost can be lower than an equivalent self-funded pathway elsewhere. But there is no responsible single percentage that applies to every cancer or treatment.
The strongest example in ChinaCureLink's current information is CAR-T, where the organisation uses a USD $80,000–$150,000 total-care planning range.
But the comparison becomes much less straightforward for surgery, chemotherapy and immunotherapy.
An Australian patient with Medicare and private insurance may have a very different personal cost from an uninsured patient. A New Zealand patient receiving a Pharmac-funded medicine may have a very different cost from someone paying privately for a non-Pharmac-funded medicine.
That means an overseas treatment should not be judged simply by comparing two advertised prices.
Instead, ask:
How much will my family actually pay from our own funds for the complete treatment pathway?
That number is the one that belongs in your financial decision.
How ChinaCureLink Helps You Understand the Real Cost before Travelling
Cost uncertainty is one of the biggest practical problems when you are considering treatment overseas. You may have a diagnosis but not yet know which treatment is clinically relevant, which Chinese hospital would handle the case, or how much the complete pathway could cost.
ChinaCureLink starts with your medical records rather than asking you to choose a treatment based on a price list. Your case can be reviewed to determine whether there appears to be a relevant treatment pathway in China.
Where appropriate, ChinaCureLink can then match your diagnosis and treatment history with a relevant hospital and specialist. Medical records can be translated, and a remote consultation can be arranged before you travel.
If a treatment pathway is proposed, the aim is to give you a written treatment plan and itemised cost estimate before you commit to travel. That allows you to compare the proposed Chinese pathway against the actual out-of-pocket cost you would face at home.
For families who proceed, ChinaCureLink can also coordinate practical arrangements including visa documentation, accommodation, airport transfers, a dedicated care manager and professional medical interpreters.
The process is simple:
Send your medical records → receive a case assessment and, where appropriate, treatment and cost information → decide whether travelling makes sense for your family.
The first step is an assessment, not a flight.
You can use that assessment to understand the potential pathway before making a major financial commitment.
Get a Second Opinion Before Fly to China
For suitable cases, ChinaCureLink can then coordinate an online consultation with the specialist to discuss the technical treatment details directly. The purpose is to help the patient understand which treatment option and which specialist center may be most appropriate before making an international treatment decision.
What Patients Say About ChinaCureLink & Medebound HEALTH
China CureLink operates under Medebound HEALTH — an internationally recognized healthcare navigation company incorporated in New York, with operations across North America and Asia-Pacific.
Rated 4.6 ⭐⭐⭐⭐⭐ at Trustpilot
Medebound HEALTH's online testimonials. Learn More
Frequently Asked Questions
How Much Does Cancer Treatment Cost in China?
There is no single price for cancer treatment in China. Costs depend on the cancer, treatment and hospital. For CAR-T, ChinaCureLink's current planning figure is USD $100,000–$150,000 for total care. Other treatments require individual quotations.
Is Cancer Treatment Cheaper in China than Australia?
It depends on the treatment and your Australian funding and insurance position. Medicare, PBS and private insurance can substantially change your personal cost. A meaningful comparison should use your actual expected out-of-pocket cost rather than an Australian hospital's gross charge.
How Much Does Private Cancer Treatment Cost in New Zealand?
Published indicative private-care figures vary substantially. One 2026 New Zealand cost guide gives chemotherapy at approximately NZD $15,000–$400,000 and radiation therapy at approximately NZD $20,000–$70,000. These are planning figures, not quotations.
How Much Does CAR-T Cost in China?
ChinaCureLink's current planning figure for total CAR-T care in China is USD $100,000–$150,000. At the 24 September 2026 Xe mid-market rate, that is approximately AUD $142,200–$213,300 or NZD $176,000–$264,000.
What is Included in the Cost of Cancer Treatment in China?
It depends on the hospital and treatment. Ask whether the quotation includes diagnostics, pathology review, medicines, treatment, hospitalisation, monitoring, specialist fees and follow-up. Also ask what happens if complications or a longer hospital stay increase the cost.
Do I Need to Pay the Full Treatment Cost Before Travelling?
Not necessarily. Payment schedules vary by hospital and treatment. Before transferring money, ask for the official invoice, deposit amount, payment deadline, refund terms and a written explanation of what the deposit covers.
About ChinaCureLink
ChinaCureLink helps patients across the world access the best cancer treatment at China's top hospitals, without the delays, language barriers, and administrative confusion that typically come with seeking care abroad.
We connect patients directly with China's top cancer hospitals, ensuring that from the first case submission through to treatment and follow-up, every step is guided, translated, and coordinated by a team experienced in cross-border patient care.
ChinaCureLink is proudly affiliated with Medebound HEALTH — founded by US physicians, with over 10 years of experience and more than 3,000 patients served worldwide, Medebound HEALTH is recognized by Forbes and it is one of the most trusted patient cross-border concierge service company across North America and the Asia Pacific.
Disclaimer
This article is for informational purposes only and is not medical or financial advice. Treatment eligibility, protocols, and costs vary by individual case — confirm specifics with a coordinator and treating physician before making any decisions.
References
Australian Government Medical Costs Finder — Australian specialist and medical-service cost information.
Cancer Australia — Costs of treatment — official Australian guidance on cancer-treatment costs.
Icon Cancer Centre — Understanding costs — Australian private cancer-care cost information.
Healthpoint NZ — Canopy Cancer Care — New Zealand private oncology information.
Policywise — Cancer treatment costs in New Zealand — indicative NZ private-care costs.
Xe — USD/AUD exchange rate — rate checked 24 September 2026.
Xe — USD/NZD exchange rate — rate checked 24 September 2026.
ChinaCureLink — CAR-T Cell Therapy Price 2026 — ChinaCureLink's current CAR-T planning figure.
Comments